Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: Influence of route of administration and cigarette smoking

Journal of Endocrinology

Volumn 162, Issue 2, 1999, Pages 265-270

  Geisler, J ^a   Omsjo I H ^b   Helle, S I ^a   Ekse, D ^a   Silsand, T ^c   Lonning P E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b Laboratory for Osteoporosis   (Norway)

^c Ctrl Lab of the Telemark Ctrl H   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; NORETHISTERONE ACETATE;

ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CROSSOVER PROCEDURE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTRONE; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; PROSPECTIVE STUDIES; SMOKING;

EID: 0032786454     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1620265     Document Type: Article

References (37)

1. Anderson DC 1974 Sex-hormone-binding globulin. Clinical Endocrinology 3 69-96.
2. Barbieri RL, Gochberg J & Ryan KJ 1986 Nicotine, cotinine and anabasine inhibit aromatase in human trophoblast in vitro. Journal of Clinical Investigation 77 1727-1733.
3. Bolt HM 1979 Metabolism of estrogens - natural and synthetic. Pharmacology and Therapeutics 4 155-181.
4. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP & Judd HL 1986 Biologic effects of transdermal estradiol. New England Journal of Medicine 314 1615-1620.
5. Conney AH 1967 Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 19 317-366.
6. Dada OA & Martins OO 1983 Drug effects on the intestinal absorption of estrogens. Journal of Steroid Biochemistry 19 821-825.
7. Daniell HW 1976 Osteoporosis of the slender smoker: vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Archives of Internal Medicine 136 298-304.
8. Doll R, Gray R, Hafner B & Peto R 1980 Mortality in relation to smoking: 22 years' observation on female British doctors. British Medical Journal 280 967-971.
9. Geola FL, Frumar AM & Tataryn IV 1980 Biological effects of various doses of conjugated equine estrogens in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 51 620-625.
10. Kiel DP, Felson DT, Anderson JJ, Wilson PWF & Moskowitz MA 1987 Hip fracture and the use of estrogens in postmenopusal women. New England Journal of Medicine 317 1169-1174.
11. Laufer LR, DeFazio JL, Lu JKH, Meldrum DR, Eggena P, Sambhi MP, Hershman JM & Judd HL 1983 Estrogen replacement therapy by transdermal estradiol administration. American Journal of Obstetrics and Gynecology 145 533-540.
12. Law MR, Cheng R, Hackshaw AK, Allaway S & Hale AK 1997 Cigarette smoking, sex hormones and bone density in women. European Journal of Epidemiology 13 553-558.
13. Lesko SM, Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Strom B, Schottenfeld D, Rosenshein NB, Knapp RC, Lewis J & Shapiro S 1985 Cigarette smoking and the risk of endometrial cancer. New England Journal of Medicine 313 593-596.
14. Lignieres Bd, Basdevant A, Thomas G, Thalabard J-C, Mercier-Bodard C, Conard J, Guyene T-T, Mairon N, Corvol P, Guy-Grand B, Mauvais-Jarvis P & Sitruk-Ware R 1986 Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. Journal of Clinical Endocrinology and Metabolism 62 536-541.
15. Lobo RA 1991 Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 73 925-930.
16. Longcope C 1972 The metabolism of estrone sulfate in normal males. Journal of Clinical Endocrinology 34 113-122.
17. 1H-estrone. Journal of Clinical Endocrinology and Metabolism 38 602-607.
18. Longcope C & Johnston CC 1988 Androgen and estrogen dynamics in pre-and post-menopausal women: a comparison between smokers and nonsmokers. Journal of Clinical Endocrinology and Metabolism 67 379-383.
19. Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J & Warram J 1985 The metabolism of estradiol; oral compared with intravenous administration. Journal of Steroid Biochemistry 23 1065-1070.
20. Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J, Morill A & Warram J 1987 The effect of a low fat diet on estrogen metabolism. Journal of Clinical Endocrinology and Metabolism 64 1246-1250.
21. Lønning PE & Kvinnsland S 1988 Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs 35 685-710.
22. Lønning PE, Kvinnsland S, Thorsen T & Ueland PM 1987 Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings. Clinical Pharmacokinetics 13 393-406.
23. Lønning PE, Johannessen DC & Thorsen T 1989 Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide. British Journal of Cancer 60 107-111.
24. Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB & Hall K 1995 Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clinical Endocrinology 42 23-30.
25. Mandel FP, Geola FL, Meldrum DR, Lu JHK, Eggena P, Sambhi MP, Hershman JM & Judd HL 1983 Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 57 133-139.
26. Meade TW 1982 Oral contraceptives, clotting factors and thrombosis. American Journal of Obstetrics and Gynecology 142 758-761.
27. Michnovicz JJ & Bradlow HL 1990 Induction of estradiol metabolism by dietary indole-3-carbinol in humans. Journal of the National Cancer Institute 82 947-949.
28. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL & Fishman J 1986 Increased 2-hydroxylarion of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. New England Journal of Medicine 315 1305-1309.
29. Muranaka H, Higashi E, Itani S & Shimizu Y 1988 Evaluation of nicotine, cotinine, thiocyanate, carboxyhemoglobin and expired carbon monoxide as biochemical tobacco smoke uptake parameters. International Archives of Occupational and Environmental Health 60 37-41.
30. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu K & Szklo M 1993 Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal of Medicine 328 1069-1075.
31. Ruder HJ, Loriaux L & Lipsett MB 1972 Estrone-sulfate: production rate and metabolism in man. Journal of Clinical Investigation 51 1020-1033.
32. Santner SJ, Feil PD & Santen RJ 1984 In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. Journal of Clinical Endocrinology and Metabolism 59 29-33.
33. Santner SJ, Leszcynski D, Wright C, Manni A, Feil PD & Santen RJ 1986 Estrone sulfate: a potential source of estradiol in human breast cancer tissue. Breast Cancer Research and Treatment 7 35-44.
34. Toone BK, Wheeler M & Fenwick PBC 1980 Sex hormone changes in male epileptics. Clinical Endocrinology 12 391-395.
35. Vesell ES & Page JG 1969 Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. Journal of Clinical Investigation 48 2202-2209.
36. Waage H, Silsand T, Urdal P & Langård S 1992 Discrimination of smoking status by thiocyanate and cotinine in serum and carbon monoxide in expired air. International Journal of Epidemiology 21 488-493.
37. Wilkinson GR & Shand DG 1975 Commentary: a physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18 377-390.